DiscoveryBioMed, Inc. Email Format

Biotechnology ResearchAlabama, United States2-10 Employees

DiscoveryBioMed, Inc. is a biotechnology research company based in Birmingham, Alabama, that focuses on integrating biologically- and disease-relevant human cell cultures and lines into the Drug Discovery Critical Path. The firm specializes in multiplexed bioassays of targets and phenotypes using mono- and multi-culture designs to support primary drug discovery and hit-to-lead validation of existing assets. It also provides custom cell culture engineering and implementation across various inflection points within the drug discovery process. DiscoveryBioMed operates as a small team (2-10 employees) and has a history of advancing human cell platforms, including a 2020 launch of such platforms and academic collaborations (e.g., with the University of Alabama at Birmingham). In July 2022, the company was acquired by Eurofins Discovery, and reported revenue is in the range of $1 million to $10 million.

Sign up for free to view info

Company overview Employee directory